Thomas G. Markees

2.2k total citations
38 papers, 1.9k citations indexed

About

Thomas G. Markees is a scholar working on Immunology, Surgery and Genetics. According to data from OpenAlex, Thomas G. Markees has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 19 papers in Surgery and 10 papers in Genetics. Recurrent topics in Thomas G. Markees's work include T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (12 papers). Thomas G. Markees is often cited by papers focused on T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (12 papers). Thomas G. Markees collaborates with scholars based in United States, United Kingdom and India. Thomas G. Markees's co-authors include Dale L. Greiner, Aldo A. Rossini, John P. Mordes, Nancy E. Phillips, Leonard D. Shultz, Randolph J. Noelle, Raymond M. Welsh, Michael A. Brehm, Neal N. Iwakoshi and Bruce A. Woda and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Thomas G. Markees

38 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas G. Markees United States 22 1.4k 618 427 297 267 38 1.9k
Joanna D. Davies United States 18 1.5k 1.1× 347 0.6× 399 0.9× 208 0.7× 124 0.5× 35 2.0k
Alan W. Steele United States 10 851 0.6× 321 0.5× 256 0.6× 160 0.5× 62 0.2× 10 1.2k
Anita Dobyszuk Poland 5 1.1k 0.8× 202 0.3× 298 0.7× 86 0.3× 159 0.6× 6 1.4k
David H. Sachs United States 15 539 0.4× 800 1.3× 279 0.7× 516 1.7× 366 1.4× 23 1.4k
Michael R. Clarkson United States 13 1.4k 1.0× 310 0.5× 114 0.3× 403 1.4× 151 0.6× 16 1.7k
Shuiping Jiang United Kingdom 17 1.4k 1.0× 202 0.3× 92 0.2× 262 0.9× 143 0.5× 30 1.7k
O. Nadazdin United States 20 602 0.4× 565 0.9× 78 0.2× 737 2.5× 217 0.8× 33 1.2k
Amy J. Reed United States 10 1.7k 1.2× 138 0.2× 225 0.5× 85 0.3× 56 0.2× 17 1.9k
Miriam Scirpoli Italy 7 675 0.5× 385 0.6× 435 1.0× 45 0.2× 39 0.1× 8 1.1k
Jana Gillies Canada 16 753 0.6× 118 0.2× 183 0.4× 64 0.2× 63 0.2× 20 1.1k

Countries citing papers authored by Thomas G. Markees

Since Specialization
Citations

This map shows the geographic impact of Thomas G. Markees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Markees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Markees more than expected).

Fields of papers citing papers by Thomas G. Markees

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas G. Markees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Markees. The network helps show where Thomas G. Markees may publish in the future.

Co-authorship network of co-authors of Thomas G. Markees

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas G. Markees. A scholar is included among the top collaborators of Thomas G. Markees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas G. Markees. Thomas G. Markees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thornley, Thomas B., Nancy E. Phillips, Britte Beaudette-Zlatanova, et al.. (2007). Type 1 IFN Mediates Cross-Talk between Innate and Adaptive Immunity That Abrogates Transplantation Tolerance. The Journal of Immunology. 179(10). 6620–6629. 59 indexed citations
2.
Yamazaki, Masahiro, Todd Pearson, Michael A. Brehm, et al.. (2007). Different Mechanisms Control Peripheral and Central Tolerance in Hematopoietic Chimeric Mice. American Journal of Transplantation. 7(7). 1710–1721. 21 indexed citations
3.
Thornley, Thomas B., Michael A. Brehm, Thomas G. Markees, et al.. (2006). TLR Agonists Abrogate Costimulation Blockade-Induced Prolongation of Skin Allografts. The Journal of Immunology. 176(3). 1561–1570. 106 indexed citations
4.
Markees, Thomas G., Todd Pearson, Amy Cuthbert, et al.. (2004). Evaluation of Donor-Specific Transfusion Sources: Unique Failure of Bone Marrow Cells to Induce Prolonged Skin Allograft Survival with Anti-CD154 Monoclonal Antibody. Transplantation. 78(11). 1601–1608. 9 indexed citations
5.
Markees, Thomas G., Nancy E. Phillips, Michael Appel, et al.. (2004). Regulation of Skin and Islet Allograft Survival in Mice Treated With Costimulation Blockade is Mediated by Different CD4+ Cell Subsets and Different Mechanisms. Transplantation. 78(5). 660–667. 28 indexed citations
6.
Phillips, Nancy E., Thomas G. Markees, John P. Mordes, Dale L. Greiner, & Aldo A. Rossini. (2003). Blockade of CD40-Mediated Signaling Is Sufficient for Inducing Islet But Not Skin Transplantation Tolerance. The Journal of Immunology. 170(6). 3015–3023. 27 indexed citations
7.
Brehm, Michael A., Thomas G. Markees, Keith A. Daniels, et al.. (2003). Direct Visualization of Cross-Reactive Effector and Memory Allo-Specific CD8 T Cells Generated in Response to Viral Infections. The Journal of Immunology. 170(8). 4077–4086. 117 indexed citations
8.
Pearson, Todd, Thomas G. Markees, David Serreze, et al.. (2003). Genetic Disassociation of Autoimmunity and Resistance to Costimulation Blockade-Induced Transplantation Tolerance in Nonobese Diabetic Mice. The Journal of Immunology. 171(1). 185–195. 59 indexed citations
9.
Pearson, Todd, Thomas G. Markees, David Serreze, et al.. (2003). Islet Cell Autoimmunity and Transplantation Tolerance: Two Distinct Mechanisms?. Annals of the New York Academy of Sciences. 1005(1). 148–156. 22 indexed citations
10.
Welsh, Raymond M., Thomas G. Markees, Bruce A. Woda, et al.. (2002). Viral Abrogation of Stem Cell Transplantation Tolerance Causes Graft Rejection and Host Death by Different Mechanisms. The Journal of Immunology. 168(12). 6047–6056. 36 indexed citations
11.
Iwakoshi, Neal N., Thomas G. Markees, Nicole A. Turgeon, et al.. (2001). Skin Allograft Maintenance in a New Synchimeric Model System of Tolerance. The Journal of Immunology. 167(11). 6623–6630. 58 indexed citations
12.
Zheng, Xin Xiao, Thomas G. Markees, Wayne W. Hancock, et al.. (1999). CTLA4 Signals Are Required to Optimally Induce Allograft Tolerance with Combined Donor-Specific Transfusion and Anti-CD154 Monoclonal Antibody Treatment. The Journal of Immunology. 162(8). 4983–4990. 148 indexed citations
13.
Markees, Thomas G., Nancy E. Phillips, Emma Gordon, et al.. (1998). Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.. Journal of Clinical Investigation. 101(11). 2446–2455. 246 indexed citations
14.
Markees, Thomas G., Nancy E. Phillips, Randolph J. Noelle, et al.. (1997). PROLONGED SURVIVAL OF MOUSE SKIN ALLOGRAFTS IN RECIPIENTS TREATED WITH DONOR SPLENOCYTES AND ANTIBODY TO CD40 LIGAND1. Transplantation. 64(2). 329–335. 133 indexed citations
15.
16.
17.
Markees, Thomas G., et al.. (1994). TOLEROGENIC BEHAVIOR OF SKIN ALLOGRAFTS FROM NEONATAL MICE. Transplantation. 58(9). 1008–1014. 3 indexed citations
18.
19.
Hartner, William C., et al.. (1991). THE EFFECT OF ANTILYMPHOCYTE SERUM, FRACTIONATED DONOR BONE MARROW, AND CYCLOSPORINE ON RENAL ALLOGRAFT SURVIVAL IN MONGREL DOGS. Transplantation. 52(5). 784–788. 20 indexed citations
20.
Hartner, William C., Sergio Fazio, Thomas G. Markees, et al.. (1987). Specific tolerance to canine renal allografts following treatment with fractionated bone marrow and antilymphocyte serum.. PubMed. 19(1 Pt 1). 476–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanna D. Davies Breakdown of academic impact, for papers by Alan W. Steele Breakdown of academic impact, for papers by Anita Dobyszuk Breakdown of academic impact, for papers by David H. Sachs Breakdown of academic impact, for papers by Michael R. Clarkson Breakdown of academic impact, for papers by Shuiping Jiang Breakdown of academic impact, for papers by O. Nadazdin Breakdown of academic impact, for papers by Amy J. Reed Breakdown of academic impact, for papers by Miriam Scirpoli Breakdown of academic impact, for papers by Jana Gillies
Rankless by CCL
2026